Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | SAE1 | Q9UBE0 | 3/20 | 0.57 |
| ▸ | UBA2 | Q9UBT2 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1022686 | 0.94 | SMN1; SMN2 (0.64) | SMN1; SMN2SAE1UBA2MAPTRAB9A | |
| SCHEMBL17518815 | 0.90 | SMN1; SMN2 (0.69) | SMN1; SMN2MAPTRAB9ANPC1HPGD | |
| SCHEMBL2097449 | 0.87 | SMN1; SMN2 (0.67) | SMN1; SMN2SAE1UBA2MAPTRAB9A | |
| SCHEMBL14802652 | 0.87 | SMN1; SMN2 (0.79) | SMN1; SMN2SAE1UBA2MAPTRAB9A | |
| SCHEMBL18183585 | 0.87 | SMN1; SMN2 (0.56) | SMN1; SMN2SAE1UBA2MAPTRAB9A | |
| SCHEMBL13647687 | 0.87 | SMN1; SMN2 (0.56) | SMN1; SMN2SAE1UBA2MAPTRAB9A | |
| SCHEMBL11134616 | 0.86 | SMN1; SMN2 (0.55) | SMN1; SMN2SAE1UBA2MAPTRAB9A | |
| SCHEMBL21456399 | 0.84 | SMN1; SMN2 (0.53) | SMN1; SMN2SAE1UBA2MAPTRAB9A | |
| SCHEMBL27101167 | 0.84 | SAE1 (0.49) | SMN1; SMN2SAE1UBA2MAPTRAB9A | |
| SCHEMBL18548480 | 0.83 | L3MBTL1 (0.61) | SMN1; SMN2SAE1UBA2MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230338257-A1 | ANHYDROUS CONCENTRATED HAIR CARE COMPOSITIONS IN THE FORM OF A PASTE | EVERIST INC. (CA) | 2023-10-26 | — | — | US | disclosed |
| WO-2016119049-A1 | METHODS OF MAKING TRIACYLGLYCEROL POLYOLS FROM FRACTIONS OF METATHESIZED NATURAL OILS AND USES THEREOF | TRENT UNIVERSITY (CA) | 2016-08-04 | — | — | WO | disclosed |
| WO-2015143562-A1 | METATHESIZED TRIACYLGLYCEROL GREEN POLYOLS FROM PALM OIL FOR USE IN POLYURETHANE APPLICATIONS AND THEIR RELATED PHYSICAL PROPERTIES | TRENT UNIVERSITY (CA) | 2015-10-01 | — | — | WO | disclosed |
| WO-2015143568-A1 | METATHESIZED TRIACYLGLYCEROL POLYOLS DERIVED FROM PALM OIL FOR USE IN POLYURETHANE APPLICATIONS AND THEIR RELATED PHYSICAL PROPERTIES | TRENT UNIVERSITY (CA) | 2015-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230338257-A1 | ANHYDROUS CONCENTRATED HAIR CARE COMPOSITIONS IN THE FORM OF A PASTE | SUCLG1, CUTA, OTC | SMN1; SMN2 3919/4885SAE1 2795/4885UBA2 3912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.